Alector, Inc. (ALEC) KPIs and segments
ALECNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3069% below fair value
$2.54+0.09 (+3.67%)
Close on Nov 13, 2026Market cap $283.61MP/E 7.3Yield –
KPIs & segments
Operating metrics and segments that drive Alector's business
Coming soon
This tab will track the numbers specific to Alector's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.
See a number that looks wrong?